HomeACTU • NASDAQ
add
Actuate Therapeutics Inc
Previous close
$6.96
Day range
$6.60 - $6.98
Year range
$5.47 - $11.99
Market cap
152.89M USD
Avg Volume
76.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.97M | 9.81% |
Net income | -5.95M | 9.48% |
Net profit margin | — | — |
Earnings per share | -0.30 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.49M | 1,746.03% |
Total assets | 6.97M | 302.63% |
Total liabilities | 9.62M | -53.17% |
Total equity | -2.65M | — |
Shares outstanding | 20.75M | — |
Price to book | -53.54 | — |
Return on assets | -260.61% | — |
Return on capital | 385.51% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.95M | 9.48% |
Cash from operations | -4.17M | -56.11% |
Cash from investing | — | — |
Cash from financing | 6.78M | 608.12% |
Net change in cash | 2.60M | 251.65% |
Free cash flow | -1.94M | -3,941.81% |
About
Founded
2015
Headquarters
Website
Employees
10
